Select Publications
Journal articles
, 2011, 'Standard Therapy for Genotypes 2/3', , pp. 90 - 96, http://dx.doi.org/10.1002/9781444346343.ch12
, 2011, 'Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C', Journal of Viral Hepatitis, 18, pp. 331 - 337, http://dx.doi.org/10.1111/j.1365-2893.2010.01310.x
, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1', GASTROENTEROLOGY, 139, pp. 1257 - 1266, http://dx.doi.org/10.1053/j.gastro.2010.06.066
, 2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3', GASTROENTEROLOGY, 139, pp. 1267 - +, http://dx.doi.org/10.1053/j.gastro.2010.06.062
, 2010, 'miR-135a*plays a key role in regulating lipogenesis and inflammation in liver diseases', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A128 - A128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'Fine positioning of T cell sub-populations in the chronic HCV-infected liver', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A284 - A284, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'Hepatic micrornas expression in obese subjects with chronic HCV', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A285 - A285, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'Intrahepatic chemokine expression and CD8+T cells in HIV/HCV co-infection compared to HCV mono-infection', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A289 - A289, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'Chronic hepatitis B infection in an Australian antenatal population: Seroprevalence and opportunities for better outcomes', Journal of Gastroenterology and Hepatology Australia, 24, pp. 998 - 1001, http://dx.doi.org/10.1111/j.1440-1746.2009.05841.x
, 2009, 'Cytokines and liver injury in chronic HCV genotype 4 infection', Journal of Gastroenterology and Hepatology, 24, pp. 332 - 335
, 2008, 'Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase', Journal of Viral Hepatitis, 15, pp. 571 - 577, http://dx.doi.org/10.1111/j.1365-2893.2008.00980.x
, 2008, 'Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?', Hepatology, 47, pp. 1418 - 1421, http://dx.doi.org/10.1002/hep.22300
, 2008, 'A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection', Hepatology, 48, pp. 374 - 384, http://dx.doi.org/10.1002/hep.22387
, 2008, 'Factors influencing the participation of gastroenterologists and hepatologists in clinical research', BMC Health Services Research, 8, pp. 1 - 11
, 2008, 'Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C', Internal Medicine Journal, 38, pp. 207 - 210, http://dx.doi.org/10.1111/j.1445-5994.2007.01625.x
, 2008, 'Treatment responses in Asians and Caucasians with chronic hepatitis C infection', World Journal of Gastroenterology, 14, pp. 3416 - 3420
, 2007, 'Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection', Journal of Translational Medicine, 5, http://dx.doi.org/10.1186/1479-5876-5-33
, 2007, 'Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?', NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 4, pp. 12 - 13, http://dx.doi.org/10.1038/ncpgasthep0694
, 2007, 'Effect of adiponectin on the cellular immune response in chronic HCV infection', Hepatology, 46, pp. 440A - 440A
, 2007, 'Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?', NATURE CLINICAL PRACTICE GASTROENTEROLOGY and HEPATOLOGY, 4, pp. 12 - 13
, 2006, 'A novel noninvasive index for prediction of hepatic fibrosis in chronic hepatitis B virus infection', Journal of Gastroenterology and Hepatology, 21, pp. A300 - A300
, 2006, 'Effect of adipokines on T-CELL mediated anti-HCV immune responses', Hepatology, 44, pp. 297A - 298A
, 2006, 'Enhanced virological responses in genotype 4 hepatitis C virus infection: a case control study', Journal of Gastroenterology and Hepatology, 21, pp. A308 - A308
, 2006, 'Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C', Journal of Gastroenterology and Hepatology, 21, pp. A323 - A323
, 2006, 'Virological responses in Asians receiving combination antiviral therapy for chronic hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 21, pp. A334 - A334
, 2005, 'Steatosis and chronic hepatitis C virus infection: Mechanisms and significance', Clinics in Liver Disease, 9, pp. 399 - 410, http://dx.doi.org/10.1016/j.cld.2005.05.007
, 2005, 'Insulin resistance and steatosis in hepatitis C virus infection', Gut, 54, pp. 903 - 906, http://dx.doi.org/10.1136/gut.2004.059873
, 2005, 'Treatment of acute hepatitis C infection: More pieces of the puzzle?', Journal of Hepatology, 42, pp. 293 - 296, http://dx.doi.org/10.1016/j.jhep.2004.12.012
, 2004, 'Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?', Nature Clinical Practice Gastroenterology and Hepatology, 1, pp. 70 - 71, http://dx.doi.org/10.1038/ncpgasthep0050
, 2004, 'Tinkering and tailoring with HCV therapy: Can we get away with less?', Hepatology, 40, pp. 1249 - 1251, http://dx.doi.org/10.1002/hep.20513
, 2004, 'A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection', Liver Transplantation, 10, pp. 52 - 57, http://dx.doi.org/10.1002/lt.20000
, 2004, 'Mechanisms of HCV reinfection and allograft damage after liver transplantation', Journal of Hepatology, 40, pp. 368 - 374, http://dx.doi.org/10.1016/j.jhep.2004.01.014
, 2003, 'Liver transplantation for HCV-associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution', Liver Transplantation, 9, pp. 339 - 347, http://dx.doi.org/10.1053/jlts.2003.50063
, 2003, 'Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation', Liver Transplantation, 9, pp. S21 - S27, http://dx.doi.org/10.1053/jlts.2003.50269
, 2003, '33 Microarray analysis of intrahepatic gene expression in different patterns of HCV recurrence post liver transplant', Hepatology, 38, pp. 171 - 171, http://dx.doi.org/10.1016/s0270-9139(03)80076-9
, 2002, 'Pathogenesis of hepatitis C virus recurrence in the liver allograft', Liver Transplantation, 8, pp. s7 - s13, http://dx.doi.org/10.1053/jlts.2002.35856
, 2002, 'Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury', Liver Transplantation, 8, pp. 292 - 301, http://dx.doi.org/10.1053/jlts.2002.31655
, 2001, 'Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I', Immunology and Cell Biology, 79, pp. 213 - 221, http://dx.doi.org/10.1046/j.1440-1711.2001.01002.x
, 2000, 'Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection', Transplant Infectious Disease, 2, pp. 166 - 185, http://dx.doi.org/10.1034/j.1399-3062.2000.020403.x
, 2000, 'Spontaneous clearance of hepatitis C virus infection post-liver transplantation is associated with rapidly changing quasispecies: A single case report', Liver Transplantation, 6, pp. 648 - 653, http://dx.doi.org/10.1053/jlts.2000.9740
Conference Papers
, 2023, ' Modulating the gut microbiota alters the gut-liver immune environment in a preclinical model of HCC', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A16 - A16, presented at International Digestive Disease Forum (IDDF), PEOPLES R CHINA, Hong Kong, 10 June 2023 - 11 June 2023, http://dx.doi.org/10.1136/gutjnl-2023-IDDF.6
, 2023, ' Shifting patterns of hepatocellular carcinoma mortality risk: the impact of socioeconomic status and ethnicity in NSW, australia', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A21 - A22, presented at International Digestive Disease Forum (IDDF), PEOPLES R CHINA, Hong Kong, 10 June 2023 - 11 June 2023, http://dx.doi.org/10.1136/gutjnl-2023-IDDF.11
, 2022, '10 GHz Compact Shunt-Diode Rectifier Circuit Using Thin Film Ag/AZO Schottky Barrier Diode for Energy Harvesting Applications', in Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics, pp. 436 - 445, http://dx.doi.org/10.1007/978-3-031-05014-5_36
, 2022, 'A 2 × 2 Array Antenna for Multi-band Energy Harvesting for Biomedical Sensing Applications', in Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics, pp. 462 - 471, http://dx.doi.org/10.1007/978-3-031-05014-5_38
, 2021, 'CONTRIBUTION OF NON-VIRAL AETIOLOGIES OF LIVER DISEASE TO THE GROWING BURDEN OF HEPATOCELLULAR CARCINOMA IN NEW SOUTH WALES', in HEPATOLOGY, WILEY, pp. 628A - 628A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'DISPARITIES IN OUTCOMES OF HEPATOCELLULAR CARCINOMA IN NEW SOUTH WALES BY SOCIOECONOMIC STATUS', in HEPATOLOGY, WILEY, pp. 634A - 635A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'METABOLIC RISK FACTORS ARE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER SURGICAL RESECTION', in HEPATOLOGY, WILEY, pp. 658A - 658A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Contribution of non-viral etiologies of liver disease to the growing burden of hepatocellular carcinoma in New South Wales', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 53 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Disparities in outcomes of hepatocellular carcinoma in New South Wales by socioeconomic status', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 17 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Metabolic risk factors are predictive of hepatocellular carcinoma recurrence after surgical resection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1